136 related articles for article (PubMed ID: 11899433)
21. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
22. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major.
Späth GF; Epstein L; Leader B; Singer SM; Avila HA; Turco SJ; Beverley SM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9258-63. PubMed ID: 10908670
[TBL] [Abstract][Full Text] [Related]
23. MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization.
Cumberbatch M; Gould SJ; Peters SW; Kimber I
Immunology; 1991 Nov; 74(3):414-9. PubMed ID: 1769690
[TBL] [Abstract][Full Text] [Related]
24. Interleukin (IL)-18 induces Langerhans cell migration by a tumour necrosis factor-alpha- and IL-1beta-dependent mechanism.
Cumberbatch M; Dearman RJ; Antonopoulos C; Groves RW; Kimber I
Immunology; 2001 Mar; 102(3):323-30. PubMed ID: 11298831
[TBL] [Abstract][Full Text] [Related]
25. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function.
Romani N; Lenz A; Glassel H; Stössel H; Stanzl U; Majdic O; Fritsch P; Schuler G
J Invest Dermatol; 1989 Nov; 93(5):600-9. PubMed ID: 2529318
[TBL] [Abstract][Full Text] [Related]
26. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
Chang CH; Furue M; Tamaki K
Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
[TBL] [Abstract][Full Text] [Related]
27. Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells.
Azukizawa H; Döhler A; Kanazawa N; Nayak A; Lipp M; Malissen B; Autenrieth I; Katayama I; Riemann M; Weih F; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2011 May; 41(5):1420-34. PubMed ID: 21469094
[TBL] [Abstract][Full Text] [Related]
28. Arsenic mobilizes Langerhans cell migration and induces Th1 response in epicutaneous protein sensitization via CCL21: a plausible cause of decreased Langerhans cells in arsenic-induced intraepithelial carcinoma.
Lee CH; Hong CH; Yu CL; Wang LF; Clausen BE; Liao WT; Huang SK; Chen GS; Yu HS
Biochem Pharmacol; 2012 May; 83(9):1290-9. PubMed ID: 22321510
[TBL] [Abstract][Full Text] [Related]
29. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207.
Stoitzner P; Holzmann S; McLellan AD; Ivarsson L; Stössel H; Kapp M; Kämmerer U; Douillard P; Kämpgen E; Koch F; Saeland S; Romani N
J Invest Dermatol; 2003 Feb; 120(2):266-74. PubMed ID: 12542532
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells.
Meindl S; Rot A; Hoetzenecker W; Kato S; Cross HS; Elbe-Bürger A
Br J Dermatol; 2005 Feb; 152(2):231-41. PubMed ID: 15727633
[TBL] [Abstract][Full Text] [Related]
31. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
32. Acute cutaneous barrier perturbation induces maturation of Langerhans' cells in hairless mice.
Katoh N; Hirano S; Kishimoto S; Yasuno H
Acta Derm Venereol; 1997 Sep; 77(5):365-9. PubMed ID: 9298129
[TBL] [Abstract][Full Text] [Related]
33. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
34. Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo.
Mummert DI; Takashima A; Ellinger L; Mummert ME
J Dermatol Sci; 2003 Nov; 33(2):91-7. PubMed ID: 14581134
[TBL] [Abstract][Full Text] [Related]
35. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75.
Wang B; Fujisawa H; Zhuang L; Kondo S; Shivji GM; Kim CS; Mak TW; Sauder DN
J Immunol; 1997 Dec; 159(12):6148-55. PubMed ID: 9550416
[TBL] [Abstract][Full Text] [Related]
36. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo.
Jakob T; Udey MC
J Immunol; 1998 Apr; 160(8):4067-73. PubMed ID: 9558117
[TBL] [Abstract][Full Text] [Related]
37. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells.
Geissmann F; Revy P; Regnault A; Lepelletier Y; Dy M; Brousse N; Amigorena S; Hermine O; Durandy A
J Immunol; 1999 Apr; 162(8):4567-75. PubMed ID: 10201996
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine 1-phospate differentially modulates maturation and function of human Langerhans-like cells.
Bock S; Pfalzgraff A; Weindl G
J Dermatol Sci; 2016 Apr; 82(1):9-17. PubMed ID: 26803226
[TBL] [Abstract][Full Text] [Related]
40. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration.
Cumberbatch M; Dearman RJ; Kimber I
Immunology; 1997 Nov; 92(3):388-95. PubMed ID: 9486113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
